EUROHLTH INTL SARL FDA Approval NDA 020459

NDA 020459

EUROHLTH INTL SARL

FDA Drug Application

Application #020459

Documents

Letter2006-04-13
Label2006-04-12
Review2019-02-15

Application Sponsors

NDA 020459EUROHLTH INTL SARL

Marketing Status

Discontinued001
Discontinued002

Application Products

001INJECTABLE;INJECTIONEQ 0.1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1REVEXNALMEFENE HYDROCHLORIDE
002INJECTABLE;INJECTIONEQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1REVEXNALMEFENE HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1995-04-17STANDARD
LABELING; LabelingSUPPL2AP2000-12-12STANDARD
LABELING; LabelingSUPPL6AP2006-04-11STANDARD

Submissions Property Types

SUPPL1Null0

CDER Filings

EUROHLTH INTL SARL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20459
            [companyName] => EUROHLTH INTL SARL
            [docInserts] => ["",""]
            [products] => [{"drugName":"REVEX","activeIngredients":"NALMEFENE HYDROCHLORIDE","strength":"EQ 0.1MG BASE\/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"REVEX","activeIngredients":"NALMEFENE HYDROCHLORIDE","strength":"EQ 1MG BASE\/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"04\/11\/2006","submission":"SUPPL-6","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020459s006lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"REVEX","submission":"NALMEFENE HYDROCHLORIDE","actionType":"EQ 0.1MG BASE\/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"REVEX","submission":"NALMEFENE HYDROCHLORIDE","actionType":"EQ 1MG BASE\/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2006-04-11
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.